The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Chen Bihua | Director, 10% Owner | Other(J) | 4.5M | — | $0 |
| Jul 1, 2026 | Chen Bihua | Director, 10% Owner | Other(J) | 2.7M | — | $0 |
| Jul 1, 2026 | Chen Bihua | Director, 10% Owner | Other(J) | 1.7M | — | $0 |
| Jul 1, 2026 | Chen Bihua | Director, 10% Owner | Other(J) | 131K | — | $0 |
| Jul 1, 2026 | Cobo Marc | Principal Accounting Officer | Tax withholding(F) | 125 | $7.80 | $975 |
| Jul 1, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | Tax withholding(F) | 343 | $7.80 | $3K |
| Jul 1, 2026 | Beltran Pedro | President and CEO, Director | Tax withholding(F) | 1K | $7.80 | $8K |
| Jul 1, 2026 | Ben Yong | Chief Med & Dev Officer | Tax withholding(F) | 1K | $7.80 | $8K |
| Jun 16, 2026 | Bauer Jake | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Tipirneni Praveen P. | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Lebowitz Peter F | Director | Grant(A) | 7K | — | $0 |
| Jun 16, 2026 | Kelleher Raymond J. | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Chen Bihua | Director, 10% Owner | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | McCormick Frank | Director | Grant(A) | 32K | — | $0 |
| Jun 16, 2026 | Kumar Neil | Director | Grant(A) | 32K | — | $0 |
| May 10, 2026 | Beltran Pedro | President and CEO, Director | Grant(A) | 1.1M | — | $0 |
| May 10, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | Grant(A) | 758K | — | $0 |
| Apr 1, 2026 | Beltran Pedro | President and CEO, Director | Tax withholding(F) | 1K | $9.03 | $9K |
| Apr 1, 2026 | Ben Yong | Chief Med & Dev Officer | Tax withholding(F) | 1K | $9.03 | $9K |
| Apr 1, 2026 | Mehra Uneek | Insider | Tax withholding(F) | 524 | $9.03 | $5K |
| Mar 24, 2026 | Lebowitz Peter F | Director | Grant(A) | 63K | — | $0 |
| Mar 10, 2026 | Ben Yong | Chief Med & Dev Officer | Grant(A) | 47K | — | $0 |
| Mar 10, 2026 | Ben Yong | Chief Med & Dev Officer | Grant(A) | 210K | — | $0 |
| Mar 10, 2026 | Beltran Pedro | Chief Scientific Officer | Grant(A) | 47K | — | $0 |
| Mar 10, 2026 | Beltran Pedro | Chief Scientific Officer | Grant(A) | 210K | — | $0 |
| Mar 10, 2026 | Mehra Uneek | Chief Financial Officer | Grant(A) | 23K | — | $0 |
| Mar 10, 2026 | Mehra Uneek | Chief Financial Officer | Grant(A) | 105K | — | $0 |
| Jan 1, 2026 | Wallace Eli M. | Chief Executive Officer, Director | Grant(A) | 1.1M | — | $0 |
| Dec 10, 2025 | Wallace Eli M. | Chief Executive Officer, Director | Disposed to issuer(D) | 1.1M | — | — |
| Oct 10, 2025 | BridgeBio Pharma, Inc. | 10% Owner | Other(J) | 785K | — | — |
| Oct 2, 2025 | Wallace Eli M. | Chief Executive Officer, Director | Grant(A) | 1.6M | — | $0 |
| Aug 26, 2025 | Mehra Uneek | Chief Financial Officer | Grant(A) | 634K | — | $0 |
| Aug 26, 2025 | Wallace Eli M. | Chief Executive Officer, Director | Grant(A) | 500K | — | $0 |
| Aug 26, 2025 | Ben Yong | Chief Med & Dev Officer | Grant(A) | 357K | — | $0 |
| Aug 26, 2025 | Beltran Pedro | Chief Scientific Officer | Grant(A) | 357K | — | $0 |
| Aug 26, 2025 | Bauer Jake | Director | Grant(A) | 138K | — | $0 |
| Aug 26, 2025 | McCormick Frank | Director | Grant(A) | 91K | — | $0 |
| Aug 26, 2025 | Tipirneni Praveen P. | Director | Grant(A) | 52K | — | $0 |
| Aug 11, 2025 | Schmid John P. | Insider | Option exercise(M) | 30K | — | — |
| Aug 11, 2025 | Schmid John P. | Insider | Option exercise(M) | 30K | — | $0 |
| Aug 11, 2025 | McKenna Mark C. | Insider | Option exercise(M) | 30K | — | — |
| Aug 11, 2025 | McKenna Mark C. | Insider | Option exercise(M) | 30K | — | $0 |
| Aug 11, 2025 | Holman Albert A III | Insider | Option exercise(M) | 30K | — | — |
| Aug 11, 2025 | Holman Albert A III | Insider | Option exercise(M) | 30K | — | $0 |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Disposed to issuer(D) | 153K | — | $0 |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Option exercise(M) | 4.2M | — | — |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 760K | $10.72 | $8.2M |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 285K | — | — |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 1.8M | — | — |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 1.9M | — | — |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 5.6M | $10.72 | $60.0M |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 639K | $10.72 | $6.9M |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Disposed to issuer(D) | 308K | — | $0 |
| Aug 11, 2025 | Chen Bihua | Director, 10% Owner | Option exercise(M) | 4.2M | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).